References: Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding

743

Views

CrossRef citations to date

Altmetric

Bibliography

Doggrell SA. The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opin Pharmacother 2012;13:1469-80
PubMed Web of Science ®Google Scholar
Spence JD. The ezetimibe “controversy” is a misunderstanding. Letter to the editor. Expert Opin Pharmacother
Google Scholar
Bogiatzi C, Spence JD. Ezetimibe and regression of carotid atherosclerosis – importance of measuring plaque burden. Stroke 2012;43:1153-5
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date